Clinical Trial Update: Chewed vs. Crushed Lanthanum Carbonate in Hemodialysis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing chewed versus crushed lanthanum carbonate in hemodialysis patients with hyperphosphatemia has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia
• Kidney Disease

Drugs mentioned

• LANTHANUM CARBONATE (lanthanum carbonate)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Hyperphosphatemia, Kidney Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-10-01